Mainz Biomed B.v. buy dimontalban
Start price
27.11.23
/
60%
€1.08
Target price
27.11.24
€2.00
Performance (%)
-0.74%
End price
09.12.23
€1.08
Summary
This prediction ended on 09.12.23 with a price of €1.08. During the runtime of the prediction for Mainz Biomed B.v. the price only changed by -0.74%. dimontalban has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Mainz Biomed B.v. | -14.583% | -14.583% |
| iShares Core DAX® | -0.315% | -2.776% |
| iShares Nasdaq 100 | 1.250% | 7.480% |
| iShares Nikkei 225® | -1.284% | -2.199% |
| iShares S&P 500 | 1.141% | 4.717% |
According to dimontalban what are the pros and cons of Mainz Biomed B.v. for the foreseeable future?
Pros
positive Cash Flow expected
Good rating
Valuable balance sheet
Very capable Management
Sustainability is important
Small cyclical dependencies
Very Future proof/growth oriented business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
High Investments for future growth
Good culture
Innovative
Some uniques
Very differentiated customer and product portfolio
Growths much faster than the competition
Stable Large shareholder and/or long term investor
Top 10 in its market
Well known brand
Cons
Very low/no dividend yield expected
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Higher risks for its business